Classification of posture in poststroke upper limb spasticity: a potential decision tool for botulinum toxin A treatment?

被引:77
作者
Hefter, Harald [2 ]
Jost, Wolfgang H. [3 ]
Reissig, Andrea [1 ]
Zakine, Benjamin [5 ]
Bakheit, Abdel Magid [6 ]
Wissel, Joerg [4 ]
机构
[1] IPSEN Pharma GmbH, D-76275 Ettlingen, Germany
[2] Univ Dusseldorf, Dept Neurol, Dusseldorf, Germany
[3] Deutsch Klin Diagnost, Dept Neurol, D-6200 Wiesbaden, Germany
[4] Kliniken Beelitz GmbH, Paracelsusring, Beelitz Heilsta, Germany
[5] Ipsen Pharma, Boulogne, France
[6] Moseley Hall Hosp, Birmingham, W Midlands, England
关键词
botulinum toxin; spasticity; stroke; upper limb; STROKE; PATHOPHYSIOLOGY; MUSCLE;
D O I
10.1097/MRR.0b013e328353e3d4
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
A significant percentage of patients suffering from a stroke involving motor-relevant central nervous system regions will develop a spastic movement disorder. Hyperactivity of different muscle combinations forces the limbs affected into abnormal postures or movement patterns. As muscular hyperactivity can effectively and safely be treated with botulinum toxin type A (BoNT-A), we present a classification of spastic arm movement patterns to support BoNT-A therapy of arm spasticity. A few characteristic patterns can be distinguished that may be relevant for BoNT-A treatment. On the basis of a differentiated posture and arm movement analysis, five characteristic arm spasticity patterns (ASP I-V) were defined with respect to the position of the shoulder, elbow, forearm, and wrist joints. These patterns were verified using data from a worldwide noninterventional Upper Limb International Survey. By clinical observation, spastic arm postures in 94% of 665 poststroke patients could be assigned to one of these five ASPs. The most frequent pattern of arm spasticity was ASP III (41.8%) with internal rotation and adduction of the shoulder and flexion at the elbow coupled with a neutral positioning of the forearm and wrist, not the typical Wernicke-Mann position. These five different arm position patterns (ASP I-V) form the foundation of a common terminology and facilitate quick and understandable exchange of information with other physicians. Furthermore, utilization of these patterns may improve the dosing, goal setting, and outcome of the BoNT-A treatment of arm spasticity.
引用
收藏
页码:227 / 233
页数:7
相关论文
共 16 条
[1]  
Adams R., 1997, Principles of Neurology, V6th
[2]  
[Anonymous], 2009, SPAST AD MAN US BOT
[3]   The burden of coronary, cerebrovascular and peripheral arterial disease [J].
Bakhai, A .
PHARMACOECONOMICS, 2004, 22 (Suppl 4) :11-18
[4]   The profile of patients and current practice of treatment of upper limb muscle spasticity with botulinum toxin type A: an international survey [J].
Bakheit, Abdel Magid ;
Zakine, Benjamin ;
Maisonobe, Pascal ;
Aymard, Claire ;
Fhedoroff, Klemens ;
Hefter, Harold ;
Jacinto, Jorge ;
Jost, Wolfgang H. ;
Molteni, Franco ;
Stam, Henk ;
Turner-Stokes, Lynne ;
Wissel, Jorg .
INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH, 2010, 33 (03) :199-204
[5]   PATHOPHYSIOLOGY OF SPASTICITY [J].
BROWN, P .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1994, 57 (07) :773-777
[6]  
Hefter H, 2009, CLASSIFICATION POSTU
[7]  
Hefter H, 2008, NEUROREHABIL NEURAL, P4
[8]   A prospective community-based study of stroke in Germany - The Erlangen Stroke Project (ESPro) incidence and case fatality at 1, 3, and 12 months [J].
Kolominsky-Rabas, PL ;
Sarti, C ;
Heuschmann, PU ;
Graf, C ;
Siemonsen, S ;
Neundoerfer, B ;
Katalinic, A ;
Lang, E ;
Gassmann, KG ;
von Stockert, TR .
STROKE, 1998, 29 (12) :2501-2506
[9]   Structural and functional changes in spastic skeletal muscle [J].
Lieber, RL ;
Steinman, S ;
Barash, IA ;
Chambers, H .
MUSCLE & NERVE, 2004, 29 (05) :615-627
[10]  
Poeck K., 2006, NEUROLOGIE